Publications en collaboration avec des chercheurs de Universidad Autónoma de Madrid (30)

2019

  1. Critically ill patients with community-onset intraabdominal infections: Influence of healthcare exposure on resistance rates and mortality

    PLoS ONE, Vol. 14, Núm. 9

2018

  1. Mapping the human brain during a specific Vojta's tactile input: The ipsilateral putamen's role

    Medicine (United States), Vol. 97, Núm. 13

  2. Population pharmacokinetics/pharmacodynamics of micafungin against Candida species in obese, critically ill, and morbidly obese critically ill patients

    Critical Care, Vol. 22, Núm. 1

2010

  1. Exposure-response analysis of tigecycline in pharmacodynamic simulations using different size inocula of target bacteria

    International Journal of Antimicrobial Agents, Vol. 36, Núm. 2, pp. 137-144

  2. Influence of media and testing methodology on susceptibility to tigecycline of Enterobacteriaceae with reported high tigecycline MIC

    Journal of Clinical Microbiology, Vol. 48, Núm. 6, pp. 2243-2246

2009

  1. Genotypic versus phenotypic characterization, with respect to β-lactam susceptibility, of Haemophilus influenzae isolates exhibiting decreased susceptibility to β-lactam resistance markers

    Antimicrobial Agents and Chemotherapy, Vol. 53, Núm. 1, pp. 267-270

  2. In vitro effect of physiological concentrations of human albumin on the antibacterial activity of tigecycline

    Journal of Antimicrobial Chemotherapy, Vol. 64, Núm. 6

  3. Influence of testing methodology on the tigecycline activity profile against presumably tigecycline-non-susceptible Acinetobacter spp

    Journal of Antimicrobial Chemotherapy, Vol. 64, Núm. 1, pp. 69-72

2008

  1. Has the licensing of respiratory quinolones for adults and the 7-valent pneumococcal conjugate vaccine (PCV-7) for children had herd effects with respect to antimicrobial non-susceptibility in invasive Streptococcus pneumoniae?

    Journal of Antimicrobial Chemotherapy, Vol. 62, Núm. 6, pp. 1430-1433

  2. High protein binding and cidal activity against penicillin-resistant S. pneumoniae: A cefditoren in vitro pharmacodynamic simulation

    PLoS ONE, Vol. 3, Núm. 7

2007

  1. Activity of cefditoren against clinical isolates of Streptococcus pneumoniae showing non-susceptibility to penicillins, cephalosporins, macrolides, ketolides or quinolones

    International Journal of Antimicrobial Agents

  2. In vitro susceptibility of Spanish isolates of Neisseria gonorrhoeae to cefditoren and five other antimicrobial agents

    International Journal of Antimicrobial Agents

  3. Influence of the β-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media

    Journal of Antimicrobial Chemotherapy, Vol. 60, Núm. 2, pp. 323-327

2005

  1. Effect of opsonophagocytosis mediated by specific antibodies on the co-amoxiclav serum bactericidal activity against Streptococcus pneumoniae after administration of a single oral dose of pharmacokinetically enhanced 2000/125 mg co-amoxiclav to healthy volunteers

    Journal of Antimicrobial Chemotherapy, Vol. 55, Núm. 5, pp. 742-747

  2. Urinary concentrations and bactericidal activity against amoxicillin-nonsusceptible strains of Escherichia coli with single-dose, oral, sustained-release amoxicillin/clavulanic acid: A phase I, open-label, noncomparative clinical trial in healthy volunteers

    Clinical Therapeutics, Vol. 27, Núm. 7, pp. 1043-1049

2004

  1. Bactericidal activity of amoxicillin against non-susceptible Streptococcus pneumoniae in an in vitro pharmacodynamic model simulating the concentrations obtained with the 2000/125 mg sustained-release co-amoxiclav formulation

    Journal of Antimicrobial Chemotherapy, Vol. 54, Núm. 6, pp. 1148-1151

2003

  1. Does Acetaminophen Interfere in the Antibiotic Treatment of Acute Otitis Media Caused by a Penicillin-Resistant Pneumococcus Strain? A Gerbil Model

    Pediatric Research, Vol. 54, Núm. 6, pp. 913-918

2001

  1. Antibacterial properties of gemifloxacin and trovafloxacin in urine ex vivo: Phase I study

    Antimicrobial Agents and Chemotherapy, Vol. 45, Núm. 6, pp. 1876-1878

  2. In vitro susceptibility of Neisseria meningitidis isolates to gemifloxacin and ten other antimicrobial agents

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 20, Núm. 2, pp. 150-151

  3. Influence of diminished susceptibility of Streptococcus pneumoniae to ciprofloxacin on the serum bactericidal activity of gemifloxacin and trovafloxacin after a single dose in healthy volunteers

    International Journal of Antimicrobial Agents, Vol. 18, Núm. 3, pp. 231-238